Skip to main content
. 2020 Jan 8;8(1):E29–E40. doi: 10.1055/a-1005-6366

Fig. 4.

Fig. 4

 Direct treatment comparison of aggressive LR solution to placebo for the prevention of post-ERCP pancreatitis.